​Legislative requirements for handling drugs, including the prescribing and supply of drugs of addiction and restricted substances

Other guides

New South Wales Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment of Opioid Dependence

Please note the following regulatory guidelines have been rescinded:

  • Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Children and Adolescents (TG181).
  • Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Adults (TG190).

Refer to Prescribe a psychostimulant medication for more information.


Current as at: Friday 10 November 2023
Contact page owner: Pharmaceutical Services